On April 15, 2021, Cisema will cohost a webinar with the Hong Kong Medical and Health Device Industries Association (HKMHDIA).
For many years, the China and Hong Kong government have been in talks to permit sales in the Greater Bay Area of medical devices listed in Hong Kong. In the last year, the policy proposal has continued to evolve. This webinar will share an overview of the recent regulatory updates and insights about the Greater Bay Area initiative as it relates to medical devices and IVDs, with a particular focus on how manufacturers might accelerate their time into the Mainland Chinese market and eventual China NMPA registration.
Details of the webinar:
Date: 15 April 2021 (Thu)
Time: 11:00AM – 12:00PM
Mr. Hamish King, Chief Operating Officer, Cisema (Hong Kong) Limited
Hamish King is a lawyer by training – admitted in Hong Kong and NSW, Australia – supporting companies with difficult regulatory affairs queries for China. Formerly with UK Magic Circle Firm Linklaters in Hong Kong, he has nearly 10 years’ experience in the legal and regulatory fields and has obtained the RAC and CFA qualifications. Regularly writing articles and speaking on China market access and regulatory pathways, he currently lives in Hong Kong and specializes in NMPA registration of medical devices. Hamish has a close interest in the regulatory implications of digital healthcare and AI applications.
Mr. Jacky Li, Sales and Marketing Manager, Cisema (Hong Kong) Limited
Jacky Li focuses on market updates of medical devices in China (including Hong Kong and the Greater Bay Area), presents market research insights in articles on Cisema’s website, and provides customized consulting services for clients.